For Schedule III substances that are mixed with at least one active, non-narcotic ingredient, which is the maximum codeine content?

Study for the Uniform MPJE Exam. Get ready with flashcards and multiple choice questions, each offering hints and explanations. Are you prepared for your pharmacy law exam?

Multiple Choice

For Schedule III substances that are mixed with at least one active, non-narcotic ingredient, which is the maximum codeine content?

Explanation:
The main concept is the codeine content limit for Schedule III combination products that include a non-narcotic active ingredient. When codeine is mixed with at least one active non-narcotic ingredient, the product is classed as Schedule III and must keep codeine to no more than 90 mg per dosing unit and no more than 1.8 g per 100 mL (or per 100 g for solids). This means the maximum allowed codeine is either 90 mg in each dosing unit or 1.8 g in 100 mL/100 g of the product, whichever applies to the formulation. Among the options, the figure that matches both limits—1.8 g per 100 mL (or 100 g) and 90 mg per dosing unit—is the correct maximum. The other numbers either exceed the per-volume/per-weight cap or don’t align with the dosing-unit limit, so they’re not correct.

The main concept is the codeine content limit for Schedule III combination products that include a non-narcotic active ingredient. When codeine is mixed with at least one active non-narcotic ingredient, the product is classed as Schedule III and must keep codeine to no more than 90 mg per dosing unit and no more than 1.8 g per 100 mL (or per 100 g for solids). This means the maximum allowed codeine is either 90 mg in each dosing unit or 1.8 g in 100 mL/100 g of the product, whichever applies to the formulation. Among the options, the figure that matches both limits—1.8 g per 100 mL (or 100 g) and 90 mg per dosing unit—is the correct maximum. The other numbers either exceed the per-volume/per-weight cap or don’t align with the dosing-unit limit, so they’re not correct.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy